The unapproved Lilly drug was confiscated in a dozen enforcement raids, part of a growing crackdown on gray-market retatrutide sellers.
Recap by typeshit. Post by The Malaysian Reserve on X.
KKM says it has seized 759 units of GLP-1 receptor agonist products worth RM405,170 since 2025 in its crackdown on unlicensed sellers.
Bhekisisa reports South Africa's regulator sees sellers on WhatsApp, Facebook and X. Inspectors close one down and another quickly takes its place.
Lincoln Journal Star reports FDA advisors are weighing whether seven unapproved peptides can be used in some compounded prescriptions.
MedPro Group points to an HHS move letting pharmacies compound six peptides that lack FDA approval. Details are in the linked story.
A physio fielding years of peptide questions says strong studies are lacking, while noting that a lack of evidence doesn't prove they fail.
Up to half of participants in the two trials of the experimental drug ended up with only mild sleep apnea, per the post.
Loading…